Abstract :Some of the fastest growing disease segments worlds over are infectious diseases, cancer, trauma/ wounds amongst others. Not many Pharma companies are involved in small molecule based research and new drug development spans over a decade, requires huge investment with high chances of failure. Venus Medicine Research Center, the R&D division of a multinational company of Indian origin Venus Remedies Limited, focuses on bringing the time and cost gap innovatively to provide solutions in the time of need especially in case of AMR where resistance patterns are changing very fast and industry just cannot afford to wait for a new drug to come. Our approach to innovation, recognizing unmet medical needs of the community and developing appropriate therapies in the field of Antimicrobial Resistance (AMR), targeted deliveries, oncology and non-oncology ICU based super specialty formulations has carved a niche for ourselves.